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ment Schemes for Specific Proteins and Autoimmune Serology have undertaken quality control surveys, and, more recently, established a quality control scheme, for C-reactive protein. In view of the importance of this protein the results are disappointing. Figure I shows the results for a series of normal samples circulated on a national basis during 1985 and 1986. More recent results using pathological samples are shown in Figure 2 ; the bars indicate the mean and the standard deviation of the logarithmically transformed data after exclusion of the outlying upper 5% and lower 5% of results. The results show that for sample I where the mean value was less protein concentration 595 mg/L) was subjected to concentration (molecular size cut-off 15000Da) followed by protein electrophoresis. Albumin comprised 13·8% and (X-I-globulin 18·4% of the protein present (the remainder being largely 'l'-globulin). Even assuming that all the (X-I-globulin fraction was (X-I-acid glycoprotein and that a maximum of 10% of this protein appeared in the Centrifree ultrafiltrate, the expected concentration in the ultrafiltrate would be II rng/L (SSA method) or 43 mg/L (benzethonium chloride method). The corresponding measured concentrations were IS rng/L and 550 mg/L, respectively. The small fraction of (X-I-acid glycoprotein which may have appeared in the ultrafiltrate of this particular sample was insufficient to account for the apparent protein concentration measured by the benzethonium chloride method.
The possible presence of an inhibitor that might decrease the analytical recovery of proteins in the SSA method is made less likely by the experiment described in my original report in which three ultrafiltrates were mixed with a urine sample containing 380 rng/L protein by both methods. No negative interference was found.
Although I accept that some urine samples may contain proteins soluble in SSA, resulting in variable underestimation of protein by this method, the evidence suggests that the benzethonium chloride method overestimates urinary protein for certain urine samples and their ultrafiltrates . than 4 mg/L results of up to 40 mg/L, clearly pathological, were obtained. Sample 2, containing rheumatoid factor, shows a surprisingly wide range of results; the samples designated by X were measured by latex agglutination methods which are known to be interfered with by immune complexes of this sort. Overall, it is evident that a significant number of laboratories provide results which are clinically grossly misleading. Every year consistently more accurate results came from the laboratories with higher resolution and where SPE strips were visually inspected prior to reporting. Overall results show a remarkable increase in technical performances and in the individual appreciation of the diagnostic value of SPE. We argue that both effects stem to some extent from the didactic and selfauditing nature of the survey itself. However, we think that the driving force of the latter is now exhausted, as shown by the decline in participant numbers and turnover, so the survey has been discontinued for the present. It might profitably resume as a quality control programme, if sufficient sample volumes were available. 
